医学研究生学报
醫學研究生學報
의학연구생학보
JOURNAL OF MEDICAL POSTGRADUATE
2015年
9期
957-961
,共5页
沈丽娟%钟芳芳%吴平平%曹晓智%卢林明
瀋麗娟%鐘芳芳%吳平平%曹曉智%盧林明
침려연%종방방%오평평%조효지%로림명
结直肠癌%预后%基因多态性%TGF-β通路
結直腸癌%預後%基因多態性%TGF-β通路
결직장암%예후%기인다태성%TGF-β통로
Colorectal cancer%Prognosis%Genetic polymorphism%TCF-βpathway
目的:既往研究发现TGF-β通路可能是影响结直肠癌预后的分子通路,由于人种遗传差异性,中国人群中是否与疾病相关尚不确定。文中探讨安徽皖南地区人群结直肠癌预后相关的遗传因素。方法纵向随访安徽省芜湖市中医医院及皖南医学院附属医院2013年1月至2014年4月收治的结直肠癌患者52例,提取DNA保存并对选取的5个候选基因进行分型,评价患者基因多态性位点( single nucleotide polymorphism, SNP)在不同遗传模型下与结直肠癌预后的关联。结果转化生长因子β( TGF-β)通路上POU2AF1基因SNP rs10749971的A等位基因在加性、隐性遗传模型下,均显著增加具有Ⅲ结直肠癌患者的复发风险(HR=1.968,P=0.004;HR=2.174,P=0.010);BMP2基因SNP rs961253的C等位基因在隐形遗传模型下,可同时增加Ⅲ期结直肠癌患者复发(HR=1.992,P=0.005)及死亡风险(HR=3.161,P=0.007),SMAD7基因SNP rs4464148的A等位基因在显性遗传模型下可显著降低Ⅱ期及Ⅲ期结直肠癌患者的死亡风险( HR=0.382, P=0.017; HR=0.230,P=0.006)。对于Ⅲ期结直肠癌患者预后的多基因累积效应显示,基因高风险组可明显增加患者的死亡风险( HR=15.512,95%CI:1.611~149.360)。结论在不同遗传模型下,TCF-β通路上的POU2AF1、BMP2及SMAD7基因的SNP位点突变与结直肠癌患者预后存在关联,且随着携带不利基因数增加,患者的死亡风险增加。
目的:既往研究髮現TGF-β通路可能是影響結直腸癌預後的分子通路,由于人種遺傳差異性,中國人群中是否與疾病相關尚不確定。文中探討安徽皖南地區人群結直腸癌預後相關的遺傳因素。方法縱嚮隨訪安徽省蕪湖市中醫醫院及皖南醫學院附屬醫院2013年1月至2014年4月收治的結直腸癌患者52例,提取DNA保存併對選取的5箇候選基因進行分型,評價患者基因多態性位點( single nucleotide polymorphism, SNP)在不同遺傳模型下與結直腸癌預後的關聯。結果轉化生長因子β( TGF-β)通路上POU2AF1基因SNP rs10749971的A等位基因在加性、隱性遺傳模型下,均顯著增加具有Ⅲ結直腸癌患者的複髮風險(HR=1.968,P=0.004;HR=2.174,P=0.010);BMP2基因SNP rs961253的C等位基因在隱形遺傳模型下,可同時增加Ⅲ期結直腸癌患者複髮(HR=1.992,P=0.005)及死亡風險(HR=3.161,P=0.007),SMAD7基因SNP rs4464148的A等位基因在顯性遺傳模型下可顯著降低Ⅱ期及Ⅲ期結直腸癌患者的死亡風險( HR=0.382, P=0.017; HR=0.230,P=0.006)。對于Ⅲ期結直腸癌患者預後的多基因纍積效應顯示,基因高風險組可明顯增加患者的死亡風險( HR=15.512,95%CI:1.611~149.360)。結論在不同遺傳模型下,TCF-β通路上的POU2AF1、BMP2及SMAD7基因的SNP位點突變與結直腸癌患者預後存在關聯,且隨著攜帶不利基因數增加,患者的死亡風險增加。
목적:기왕연구발현TGF-β통로가능시영향결직장암예후적분자통로,유우인충유전차이성,중국인군중시부여질병상관상불학정。문중탐토안휘환남지구인군결직장암예후상관적유전인소。방법종향수방안휘성무호시중의의원급환남의학원부속의원2013년1월지2014년4월수치적결직장암환자52례,제취DNA보존병대선취적5개후선기인진행분형,평개환자기인다태성위점( single nucleotide polymorphism, SNP)재불동유전모형하여결직장암예후적관련。결과전화생장인자β( TGF-β)통로상POU2AF1기인SNP rs10749971적A등위기인재가성、은성유전모형하,균현저증가구유Ⅲ결직장암환자적복발풍험(HR=1.968,P=0.004;HR=2.174,P=0.010);BMP2기인SNP rs961253적C등위기인재은형유전모형하,가동시증가Ⅲ기결직장암환자복발(HR=1.992,P=0.005)급사망풍험(HR=3.161,P=0.007),SMAD7기인SNP rs4464148적A등위기인재현성유전모형하가현저강저Ⅱ기급Ⅲ기결직장암환자적사망풍험( HR=0.382, P=0.017; HR=0.230,P=0.006)。대우Ⅲ기결직장암환자예후적다기인루적효응현시,기인고풍험조가명현증가환자적사망풍험( HR=15.512,95%CI:1.611~149.360)。결론재불동유전모형하,TCF-β통로상적POU2AF1、BMP2급SMAD7기인적SNP위점돌변여결직장암환자예후존재관련,차수착휴대불리기인수증가,환자적사망풍험증가。
Objective Previous study found TGF-βpathway might be the molecular pathway influencing the prognosis of colo-rectal cancer, while it was uncertain whether Chinese population is associated with the disease.The article was to evaluate the genetic factors associated with prognosis in colorectal cancer. Methods 52 cases patients with colorectal cancer were followed-up for 36 months in our hospitals from January 2013 to August 2014.Their DNAs were extracted and stored and gene typing were carried out in 5 candidate genes to detect the association between SNPs and the prognosis in colorectal cancer. Results The results showed that within the TGF-βsignaling pathway, after adjusting for Bonferroni multiple testing, allele A of SNP rs10749971 located in gene POU2AF1 was associated with the recurrence of patients with stage III disease under additive and recessive genetic models ( HR =1.968, P=0.004;HR=2.174, P=0.010).Allele C of SNP rs961253 in the gene BMP2 could increase the recurrence risk (HR=1.992, P=0.005) and the death risk (HR=3.161, P=0.007) of patients with stage III disease under recessive genetic models.Allele A of SNP rs4464148 in SMAD7 gene could significantly decrease the death risk of patients with stage II and III colorectal cancer under dominant genetic model (HR=0.382, P=0.017;HR=0.230, P=0.006).In addition, accumulated effects of several adverse genes showed gene high risk group could increase the risk of death for patients with stage III colorectal cancer significantly ( HR=15.512, P=0.036;95%CI:1.611-149.360). Conclusion In different genetic models, SNP locus mutation within gene POU2AF1, BMP2 and SMAD7 on TGF-βpathway was associated with the prognosis of patients with colorectal cancer.With the increase of the number of unfavorable genes, the death risk increases accordingly.